Your browser doesn't support javascript.
loading
Background and Update for S1602 "A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naïve High-grade Non-muscle-invasive Bladder Cancer.
Svatek, Robert S; Tangen, Cathy; Delacroix, Scott; Lowrance, William; Lerner, Seth P.
Afiliação
  • Svatek RS; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA. Electronic address: svatek@uthscsa.edu.
  • Tangen C; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Delacroix S; Louisiana State University, Department of Urology and Gulf South NCORP, New Orleans, LA, USA.
  • Lowrance W; Department of Urology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Lerner SP; Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Eur Urol Focus ; 4(4): 522-524, 2018 07.
Article em En | MEDLINE | ID: mdl-30197040

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article